Considering S glycoprotein as the main structural protein with key roles at the early viral life cycle, targeting S glycoprotein can significantly reduce viral infection and subsequent disease symptoms by blocking entry and subsequent replication of SARS-CoV-2. Here, ART4 is linked to viral infectious disease.